A Randomized, Double blind, Active Control Study of the

Project: Research project

Project Details

Description

A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta
StatusFinished
Effective start/end date8/1/175/29/20

Funding

  • Protalix Ltd.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.